Editoriale AJKD Vol XX | Iss XX | Month 2022
In this issue of AJKD, Wang et al1 report on the incidence, trends, and consequences of treatment of posttransplant hyperparathyroidism in a nationwide registry encompassing 30,127 Medicare-insured US patients who received a first kidney transplant.
…In clinical practice, we want to identify patients with negative effects of PTH on target organs—such as high bone turnover with risk of bone demineralization, or excessive calciuria with risk of kidney stones and nephrocalcinosis…
0
